187 related articles for article (PubMed ID: 24074925)
1. The effect of radiation timing on patients with high-risk features of parameningeal rhabdomyosarcoma: an analysis of IRS-IV and D9803.
Spalding AC; Hawkins DS; Donaldson SS; Anderson JR; Lyden E; Laurie F; Wolden SL; Arndt CA; Michalski JM
Int J Radiat Oncol Biol Phys; 2013 Nov; 87(3):512-6. PubMed ID: 24074925
[TBL] [Abstract][Full Text] [Related]
2. Influence of radiation therapy parameters on outcome in children treated with radiation therapy for localized parameningeal rhabdomyosarcoma in Intergroup Rhabdomyosarcoma Study Group trials II through IV.
Michalski JM; Meza J; Breneman JC; Wolden SL; Laurie F; Jodoin M; Raney B; Wharam MD; Donaldson SS
Int J Radiat Oncol Biol Phys; 2004 Jul; 59(4):1027-38. PubMed ID: 15234036
[TBL] [Abstract][Full Text] [Related]
3. Local Control for Intermediate-Risk Rhabdomyosarcoma: Results From D9803 According to Histology, Group, Site, and Size: A Report From the Children's Oncology Group.
Wolden SL; Lyden ER; Arndt CA; Hawkins DS; Anderson JR; Rodeberg DA; Morris CD; Donaldson SS
Int J Radiat Oncol Biol Phys; 2015 Dec; 93(5):1071-6. PubMed ID: 26581144
[TBL] [Abstract][Full Text] [Related]
4. Parameningeal rhabdomyosarcoma: outcomes and opportunities.
Yang JC; Wexler LH; Meyers PA; Wolden SL
Int J Radiat Oncol Biol Phys; 2013 Jan; 85(1):e61-6. PubMed ID: 23021437
[TBL] [Abstract][Full Text] [Related]
5. Treatment of children and adolescents with localized parameningeal sarcoma: experience of the Intergroup Rhabdomyosarcoma Study Group protocols IRS-II through -IV, 1978-1997.
Raney RB; Meza J; Anderson JR; Fryer CJ; Donaldson SS; Breneman JC; Fitzgerald TJ; Gehan EA; Michalski JM; Ortega JA; Qualman SJ; Sandler E; Wharam MD; Wiener ES; Maurer HM; Crist WM
Med Pediatr Oncol; 2002 Jan; 38(1):22-32. PubMed ID: 11835233
[TBL] [Abstract][Full Text] [Related]
6. Effect of radiotherapy techniques (IMRT vs. 3D-CRT) on outcome in patients with intermediate-risk rhabdomyosarcoma enrolled in COG D9803--a report from the Children's Oncology Group.
Lin C; Donaldson SS; Meza JL; Anderson JR; Lyden ER; Brown CK; Morano K; Laurie F; Arndt CA; Enke CA; Breneman JC
Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1764-70. PubMed ID: 21470795
[TBL] [Abstract][Full Text] [Related]
7. Delayed radiotherapy following dose intensive chemotherapy for parameningeal rhabdomyosarcoma (PM-RMS) of childhood.
Douglas JG; Arndt CA; Hawkins DS
Eur J Cancer; 2007 Apr; 43(6):1045-50. PubMed ID: 17368885
[TBL] [Abstract][Full Text] [Related]
8. Cranial nerve palsies in childhood parameningeal rhabdomyosarcoma.
Zorzi AP; Grant R; Gupta AA; Hodgson DC; Nathan PC
Pediatr Blood Cancer; 2012 Dec; 59(7):1211-4. PubMed ID: 22408065
[TBL] [Abstract][Full Text] [Related]
9. Early treatment failure in intermediate-risk rhabdomyosarcoma: results from IRS-IV and D9803--a report from the Children's Oncology Group.
Minn AY; Lyden ER; Anderson JR; Million L; Arndt CA; Brown K; Hawkins DS; Donaldson SS
J Clin Oncol; 2010 Sep; 28(27):4228-32. PubMed ID: 20713850
[TBL] [Abstract][Full Text] [Related]
10. Proton radiotherapy for parameningeal rhabdomyosarcoma: clinical outcomes and late effects.
Childs SK; Kozak KR; Friedmann AM; Yeap BY; Adams J; MacDonald SM; Liebsch NJ; Tarbell NJ; Yock TI
Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):635-42. PubMed ID: 21377294
[TBL] [Abstract][Full Text] [Related]
11. Volumetric considerations in radiotherapy for pediatric parameningeal rhabdomyosarcomas.
Chen C; Shu HK; Goldwein JW; Womer RB; Maity A
Int J Radiat Oncol Biol Phys; 2003 Apr; 55(5):1294-9. PubMed ID: 12654440
[TBL] [Abstract][Full Text] [Related]
12. Benefit of intensified therapy for patients with local or regional embryonal rhabdomyosarcoma: results from the Intergroup Rhabdomyosarcoma Study IV.
Baker KS; Anderson JR; Link MP; Grier HE; Qualman SJ; Maurer HM; Breneman JC; Wiener ES; Crist WM
J Clin Oncol; 2000 Jun; 18(12):2427-34. PubMed ID: 10856103
[TBL] [Abstract][Full Text] [Related]
13. Improved prognosis with intensive treatment of children with cranial soft tissue sarcomas arising in nonorbital parameningeal sites. A report from the Intergroup Rhabdomyosarcoma Study.
Raney RB; Tefft M; Newton WA; Ragab AH; Lawrence W; Gehan EA; Maurer HM
Cancer; 1987 Jan; 59(1):147-55. PubMed ID: 3791141
[TBL] [Abstract][Full Text] [Related]
14. Influence of noncompliance with radiation therapy protocol guidelines and operative bed recurrences for children with rhabdomyosarcoma and microscopic residual disease: a report from the Children's Oncology Group.
Million L; Anderson J; Breneman J; Hawkins DS; Laurie F; Michalski J; Rodeberg D; Wharam M; Wolden S; Donaldson SS;
Int J Radiat Oncol Biol Phys; 2011 Jun; 80(2):333-8. PubMed ID: 20646841
[TBL] [Abstract][Full Text] [Related]
15. Outcome and Patterns of Relapse in Childhood Parameningeal Rhabdomyosarcoma Treated With Proton Beam Therapy.
Doyen J; Jazmati D; Geismar D; Frisch S; Schleithoff SS; Vermeren X; Scheer M; Blase C; Tippelt S; Timmermann B
Int J Radiat Oncol Biol Phys; 2019 Dec; 105(5):1043-1054. PubMed ID: 31419513
[TBL] [Abstract][Full Text] [Related]
16. Rhabdomyosarcoma of the parotid region occurring in childhood and adolescence. A report from the Intergroup Rhabdomyosarcoma Study Group.
Walterhouse DO; Pappo AS; Baker KS; Parham DM; Anderson JR; Donaldson SS; Paidas CN; Womer RB; Crist WM
Cancer; 2001 Dec; 92(12):3135-46. PubMed ID: 11753993
[TBL] [Abstract][Full Text] [Related]
17. Results from the IRS-IV randomized trial of hyperfractionated radiotherapy in children with rhabdomyosarcoma--a report from the IRSG.
Donaldson SS; Meza J; Breneman JC; Crist WM; Laurie F; Qualman SJ; Wharam M;
Int J Radiat Oncol Biol Phys; 2001 Nov; 51(3):718-28. PubMed ID: 11597814
[TBL] [Abstract][Full Text] [Related]
18. Intensive induction chemotherapy and delayed irradiation in the management of parameningeal rhabdomyosarcoma.
Smith SC; Lindsley SK; Felgenhauer J; Hawkins DS; Douglas JG
J Pediatr Hematol Oncol; 2003 Oct; 25(10):774-9. PubMed ID: 14528099
[TBL] [Abstract][Full Text] [Related]
19. Patterns of failure and toxicity profile following proton beam therapy for pediatric bladder and prostate rhabdomyosarcoma.
Buszek SM; Ludmir EB; Grosshans DR; McAleer MF; McGovern SL; Harrison DJ; Okcu MF; Chintagumpala MM; Mahajan A; Paulino AC
Pediatr Blood Cancer; 2019 Nov; 66(11):e27952. PubMed ID: 31397065
[TBL] [Abstract][Full Text] [Related]
20. Histology, Fusion Status, and Outcome in Alveolar Rhabdomyosarcoma With Low-Risk Clinical Features: A Report From the Children's Oncology Group.
Arnold MA; Anderson JR; Gastier-Foster JM; Barr FG; Skapek SX; Hawkins DS; Raney RB; Parham DM; Teot LA; Rudzinski ER; Walterhouse DO
Pediatr Blood Cancer; 2016 Apr; 63(4):634-9. PubMed ID: 26756883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
